BRIGHT MINDS BIOSCIENCES INC. - Common Shares, no par value (DRUG)
CUSIP: 10919W405
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 9,846,380
- Total 13F shares
- 197,030
- Share change
- -15,733
- Total reported value
- $207,191
- Price per share
- $1.05
- Number of holders
- 5
- Value change
- -$19,280
- Number of buys
- 1
- Number of sells
- 2
Quarterly Holders Quick Answers
What is CUSIP 10919W405?
CUSIP 10919W405 identifies DRUG - BRIGHT MINDS BIOSCIENCES INC. - Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 10919W405:
Top shareholders of DRUG - BRIGHT MINDS BIOSCIENCES INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AdvisorShares Investments LLC |
13F
|
Company |
1.8%
|
176,038
|
$211,246 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.18%
|
17,829
|
$21,395 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.14%
|
13,795
|
$16,553 | — | 31 Mar 2024 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.05%
|
5,000
|
$5,248 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
612
|
$1,000 | — | 31 Mar 2024 | |
| Aspire Private Capital, LLC |
13F
|
Company |
0%
|
100
|
$120 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Mar 2024 |
Institutional Holders of BRIGHT MINDS BIOSCIENCES INC. - Common Shares, no par value (DRUG) as of Q2 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.